Trademark: 79321251
Word
TYVCODO
Status
Registered
Status Code
700
Status Date
Tuesday, June 28, 2022
Serial Number
79321251
Registration Number
6770234
Registration Date
Tuesday, June 28, 2022
Mark Type
4000
Filing Date
Tuesday, May 11, 2021
Published for Opposition
Tuesday, April 12, 2022

Trademark Owner History
Sandoz AG -
NOVARTIS AG - Original Registrant

Classifications
5 Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Trademark Events
Jan 19, 2024
Change Of Owner Received From Ib
Nov 1, 2022
Final Decision Transaction Processed By Ib
Oct 12, 2022
Final Disposition Notice Sent To Ib
Oct 12, 2022
Final Disposition Processed
Sep 28, 2022
Final Disposition Notice Created, To Be Sent To Ib
Jun 28, 2022
Notice Of Registration Confirmation Emailed
Jun 28, 2022
Registered-Principal Register
Apr 12, 2022
Official Gazette Publication Confirmation E-Mailed
Apr 12, 2022
Published For Opposition
Mar 23, 2022
Notification Of Notice Of Publication E-Mailed
Mar 5, 2022
Approved For Pub - Principal Register
Feb 28, 2022
Refusal Processed By Ib
Feb 10, 2022
Teas/Email Correspondence Entered
Feb 9, 2022
Correspondence Received In Law Office
Feb 9, 2022
Teas Response To Office Action Received
Feb 8, 2022
Applicant/Correspondence Changes (Non-Responsive) Entered
Feb 8, 2022
Teas Change Of Correspondence Received
Feb 8, 2022
Teas Change Of Domestic Representatives Address
Feb 8, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Feb 8, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Feb 8, 2022
Teas Change Of Owner Address Received
Feb 4, 2022
Non-Final Action Mailed - Refusal Sent To Ib
Feb 4, 2022
Refusal Processed By Mpu
Jan 13, 2022
Non-Final Action (Ib Refusal) Prepared For Review
Jan 12, 2022
Non-Final Action Written
Jan 12, 2022
Assigned To Examiner
Oct 12, 2021
Application Filing Receipt Mailed
Oct 6, 2021
New Application Office Supplied Data Entered
Sep 30, 2021
Limitation From Original Application Entered
Sep 30, 2021
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24